- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02417948
Improving Sun-Protective Behaviors and Skin Self-Examinations Among African Americans
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
PRIMARY OBJECTIVES:
I. To assess whether an educational brochure and online program will increase sun-protective behaviors among African-American patients who present at the general dermatology clinic.
SECONDARY OBJECTIVES:
I. To assess whether the educational brochure and online program will improve skills for skin self-examinations among African-American patients who present at the general dermatology clinic.
OUTLINE: Participants are assigned to 1 of 2 arms.
ARM I: Participants receive a skin cancer educational and preventive brochure distributed by the National Cancer Institute and watch a 30-minute online tutorial video called X-Plain about skin cancer, preventative behaviors, and skin self-examinations.
ARM II: Participants receive an educational brochure as in Arm I.
After completion of study, participants are followed up at 30 days.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44106-5065
- Case Comprehensive Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Self-identified African-Americans who are literate and fluent in English
Exclusion Criteria:
- Non-African-Americans
- English illiteracy
- non-fluency in English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arm I (educational brochure, online educational tutorial)
Participants receive a skin cancer educational and preventive brochure distributed by the National Cancer Institute and watch a 30-minute online tutorial video called X-Plain about skin cancer, preventative behaviors, and skin self-examinations.
|
Receive brochure with skin cancer education and preventative information
Other Names:
Watch 30-minute online tutorial video about skin cancer, preventive behaviors, and skin self-examinations
Other Names:
|
|
Active Comparator: Arm II (educational brochure)
Participants receive an educational brochure as in Arm I.
|
Receive brochure with skin cancer education and preventative information
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in sunscreen use among African-American patients
Time Frame: Baseline to day 30
|
Change in sun-protective behaviors among African-American patients.
Measured by sunscreen use.
All responses for questions about sun-protective behaviors are on a 5-point Likert scale.
Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups.
The outcome variable is a continuous variable.
Treatment scores individuals on the intervention group will be compared.
T-tests will be used to compare mean scores for sun-protective behaviors between control and treatment groups.
|
Baseline to day 30
|
|
Change in apparel use when exposed to sun among African-American patients
Time Frame: Baseline to day 30
|
Change in sun-protective behaviors among African-American patients.
Measured by apparel use when exposed to sun.
All responses for questions about sun-protective behaviors are on a 5-point Likert scale.
Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups.
The outcome variable is a continuous variable.
Treatment scores individuals on the intervention group will be compared.
T-tests will be used to compare mean scores for sun-protective behaviors between control and treatment groups.
|
Baseline to day 30
|
|
Change in frequency of tanning among African-American patients
Time Frame: Baseline to day 30
|
Change in sun-protective behaviors among African-American patients.
Measured by frequency of tanning.
All responses for questions about sun-protective behaviors are on a 5-point Likert scale.
Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups.
The outcome variable is a continuous variable.
Treatment scores individuals on the intervention group will be compared.
T-tests will be used to compare mean scores for sun-protective behaviors between control and treatment groups.
|
Baseline to day 30
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in skin self-examinations among African-American patients as measured by knowledge, behavior and anxiety
Time Frame: Baseline to day 30
|
Analyzed by looking at increase or decrease in skin self-examinations the patients report from pre-intervention to post-intervention.
Performance of skin self-examination is measured by knowledge, behavior, and anxiety.
Most responses for questions about skin self-examinations are on a 5-point Likert scale, while some are yes/no or true/false.
Summary scores will be created at baseline and short-term (1 month) follow-up for both control and treatment groups.
The outcome variable is a continuous variable.
T-tests will be used to compare mean scores for skin self-examinations between groups.
|
Baseline to day 30
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jeremy Bordeaux, Case Comprehensive Cancer Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CASE1615 (Other Identifier: Case Comprehensive Cancer Center)
- P30CA043703 (U.S. NIH Grant/Contract)
- NCI-2015-00481 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Carcinoma
-
National Cancer Institute (NCI)SuspendedStage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 | Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 | Eyelid Squamous Cell Carcinoma | Skin Acantholytic Squamous Cell Carcinoma | Skin Clear Cell Squamous Cell Carcinoma | Skin Lymphoepithelial Carcinoma | Skin Spindle... and other conditionsUnited States, Australia, Canada
-
Elucid Labs Inc.UnknownMelanoma (Skin) | Squamous Cell Carcinoma of the Skin | Basal Cell Carcinoma of the SkinCanada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingSkin Squamous Cell Carcinoma | Metastatic Skin CancerUnited States
-
Salzburger LandesklinikenBristol-Myers SquibbRecruitingSquamous Cell Carcinoma of the SkinAustria
-
Kirsten JohnsonRecruitingSkin Squamous Cell Carcinoma | Skin Basal Cell Carcinoma | Skin Nodular Basal Cell CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingRecurrent Skin Squamous Cell Carcinoma | Resectable Skin Squamous Cell Carcinoma | Stage I Skin Cancer | Stage II Skin Cancer | Stage III Skin CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Neuroendocrine Carcinoma of the Skin | Stage III Neuroendocrine Carcinoma of the Skin | Stage IV Neuroendocrine Carcinoma of the Skin | Stage II Neuroendocrine Carcinoma of the Skin | Stage I Neuroendocrine Carcinoma of the SkinUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.RecruitingAdvanced Basal Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingSkin Cancer | Squamous Cell Carcinoma | Cutaneous Squamous Cell Carcinoma | Locally Advanced Skin Squamous Cell Carcinoma | Locally Advanced Cutaneous Squamous Cell Carcinoma | Locally Advanced Squamous Cell Carcinoma | Locally Advanced Squamous Cell Carcinoma of the SkinUnited States
-
Melanoma Institute AustraliaCompletedSkin Cancer | Basal Cell Carcinoma | Invasive Carcinoma | Basal Cell Carcinoma of Skin, Site UnspecifiedAustralia
Clinical Trials on Written Educational Brochure
-
Mayo ClinicNational Institute on Minority Health and Health Disparities (NIMHD); Mountain...CompletedBreast CancerUnited States
-
Milton S. Hershey Medical CenterCompletedChemotherapy Effect | Chemotherapeutic Toxicity | Chemotherapeutic Agent ToxicityUnited States
-
UNC Lineberger Comprehensive Cancer CenterRecruitingBreast Cancer | Breast Cancer MetastaticUnited States
-
University Health Network, TorontoEnrolling by invitationParkinson Disease | Dementia | Alzheimer Disease | Vascular Dementia | Frontotemporal Lobar Degeneration | Neuro-Degenerative Disease | Caregiver BurnoutCanada
-
Western Kentucky UniversityRecruitingPregnancy Related | PostpartumUnited States
-
University of Colorado, DenverThe Henry J. Kaiser Family FoundationCompletedColonoscopy | Mass ScreeningUnited States
-
Universidad de GranadaNot yet recruitingAsthma | Allergy
-
Medical College of WisconsinVersiti; Healthier Wisconsin Partnership Program; National Anemia Action CouncilCompletedAnemia | Colorectal CancerUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoPatient-Centered Outcomes Research InstituteCompleted
-
Mayo ClinicTerminatedPatient Education in Radiation OncologyUnited States